N Raverdy

2.0k citations
36 papers · 1.1k indexed · h-index 16

N Raverdy

36 papers receiving 1.0k citations

Peers

N Raverdy
Comparison fields: 5 of 80
  • Oncology 643
  • Pathology and Forensic Medicine 194
  • Genetics 109
  • Cancer Research 116
  • Endocrinology, Diabetes and Metabolism 122
Replace Arlene S. Swern with:
Arlene S. Swern United States
Şefik İğdem Türkiye
Patrick Berteloot Belgium
M. Colman United States
Britta Mattsson Sweden
Terenig Terjanian United States
Heinz Tüchler Austria
P Carli France
R. Pieters Netherlands
N Raverdy relative to Arlene S. Swern United States Arlene S. Swern's profile →
Citations per field
00.5×1.5×2.0×
Arlene S. Swern · 1×
Citations per year

Countries citing papers authored by N Raverdy

Since Specialization
Citations

This map shows the geographic impact of N Raverdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Raverdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Raverdy more than expected).

Fields of papers citing papers by N Raverdy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Raverdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Raverdy. The network helps show where N Raverdy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside N Raverdy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N Raverdy Line = papers co-authored together N Raverdy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200734
2 2007119
3 200711
4 20065
5 2005106
6 200410
7 200437
8 20041
9 200433
10 200410
11 200318
12
[Lip, oral cavity and pharynx cancers in France: incidence, mortality and trends (period 1975-1995)].
200212
13 200139
14 200121
15 20016
16 200031
17 199931
18
Les cancers génitaux et mammaires féminins en France : répartition géographique et estimation de l’incidence
19974
19 199790
20 1997111

About N Raverdy

N Raverdy is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Screening and Detection (17 papers), Global Cancer Incidence and Screening (13 papers), Colorectal Cancer Surgical Treatments (7 papers), Multiple and Secondary Primary Cancers (7 papers), Breast Cancer Treatment Studies (4 papers), Cancer Risks and Factors (4 papers), Genetic factors in colorectal cancer (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (643 citations), Pathology and Forensic Medicine (194 citations) and Genetics (109 citations). N Raverdy has collaborated with scholars based in France, Italy and United Kingdom. Frequent co-authors include Pascale Grosclaude, P. Arveux, Jean Faivre, Guy Launoy, Marc Colonna, M Gignoux, Paul Schaffer, O. Ganry, Hélène Mathieu‐Daudé and J Maurel. Their work appears in journals such as Cancer, Gut and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026